News & Events
- 'Turning Science into Business' AI & ML summit: Navigating AI-driven drug discovery
- Transforming Target and Drug Discovery with Visual Biology derived AI Disease Models
- Visual biology AI neural network recognize disease signatures in cellular pathway visualizations
- Leveraging large-scale mRNA biology data to advance disease understanding
- mRNA Is Never Naked: Exploring RBP Target Space & Therapeutic Opportunities
- Technologies developed to study mRNA life cycle
- Exposing hidden targets within the mRNA regulation space
-
19th Annual Biotech in Europe Forum Hosted by Sachs Associates
When:
Where: Basel, SwitzerlandAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 19th Annual Biotech in Europe Forum hosted by Sachs Associates. Yochi Slonim, Co-founder and Chief Executive Offer of Anima Biotech, will also participate on a “Platform Technologies & Novel Therapeutics” panel.
The Biotech in Europe Forum is the leading international stage for those interested in investing and partnering in the biotech industry. This event unites companies of all stages with leading investors, analysts, money managers and pharma licensing executives. Sachs estimates over 700 delegates and over 100 presenting companies, and 30+ pitches by seed companies.
-
Inaugural RNA as a Drug Target Program as Part of the 17th Annual Discovery on Target Conference
When:
Where: Boston, USAAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that specifically control mRNA translation during the 17th Annual Discovery on Target Conference in the Inaugural RNA as a Drug Target Program.
The Discovery on Target conference series is the industry’s preeminent event on novel drug targets and technologies. The RNA as a Drug Target program allows scientific leaders and biotech executives from around the world to collaborate about expanding the boundaries of druggable targets.
-
12th Annual BioPharm America International Partnering Conference
When:
Where: Boston, USAAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that specifically control mRNA translation during the 12th Annual BioPharm America International Partnering Conference.
BioPharm America propels the future of drug development by bringing attendees unequaled value and unparalleled access to global decision makers in an elevated format that highlights innovation. The conference allows registrants to meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic partnerships.
-
2019 BIO International Convention
When:
Where: Philadelphia, USAAnima Biotech has been invited to present an overview of its business and strategy during the 2019 BIO International Convention.
The BIO International Convention is packed with the latest trends, technologies, companies and breakthrough ideas in biotech and pharma. The convention now boasts more than 1,800 exhibiting companies and delegations from 67 countries and hosts a variety of activities and provides opportunities to learn more about how attendees can help fuel the next big breakthrough.
-
European High Content Screening User Group Meeting
When:
Where: Barcelona, SpainAnima Biotech has been invited to present about the discovery of Protein Synthesis Modulators of "Undruggable" Targets using its Translation Control Therapeutics platform during the European High Content Screening User Group Meeting.
The European High Content Screening User Group Meeting provides a unique opportunity for users to appreciate the broad diversity of HCS applications; gain insights into new workflow solutions; share their experience, discuss challenges and learn about technology updates.
-
11th Annual International ChinaBio Partnering Forum 2019
When:
Where: Shanghai, ChinaAnima Biotech has been invited to present about its business, technology and partnering strategies during the 11thAnnual International ChinaBio Partnering Forum 2019.
The ChinaBio Partnering Forum is the premier life science partnering event in China. The event will attract biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. -
BioCentury 26th Annual Future Leaders in the Biotech Industry Conference
When:
Where: New York, USAAnima Biotech has been invited to present and participate on a panel during the BioCentury 26th Annual Future Leaders in the Biotech Industry Conference.
The Future Leaders Class of 2019 will showcase the next wave of investment opportunities in redefining disease, expanding the world of druggable targets, advancing next-generation modalities and applying AI to drug development.
-
13th Annual BIO-Europe Spring International Partnering Conference
When:
Where: Vienna, AustriaAnima Biotech has been invited to present about its business, technology and partnering strategies during the 13th Annual BIO-Europe Spring International Partnering Conference.
The Annual BIO-Europe Spring Conference is Europe’s largest springtime biotech partnering event. The conference attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and mid-size pharmaceutical companies, investors and other industry experts.
-
2019 BIO Asia
When:
Where: Tokyo, JapanAnima Biotech has been invited to present about its business and partnering strategies at the 2019 BIO Asia International Conference.
The Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements.
-
12th Annual European Life Sciences CEO Forum
When:
Where: Zurich, SwitzerlandAnima Biotech has been invited to both present and participate on a panel during the 12th Annual European Life Sciences CEO Forum.
Back for its 12th Annual edition, the global biopharma industry forum addresses through its conference the main challenges for 2019 in investment, partnering and alliance management. Key players contribute their insights in panels, which cover the macro picture as well as innovation in the different therapeutic sectors.